Recombinant Human NXNL2 Protein ，His & SUMO

NXNL2, a member of the N-terminally extended NRL family, has garnered significant attention in recent years due to its crucial role in retinal health and function. It is primarily expressed in retinal photoreceptors, where it is believed to play a vital role in phototransduction and the protection of photoreceptor cells from stress-induced apoptosis. Research has indicated that mutations in the NXNL2 gene can lead to various forms of inherited retinal dystrophies, which often present with severe visual impairment or blindness. Given its importance in retinal biology, scientists have focused on the characterization of NXNL2 as a recombinant protein to understand its molecular mechanisms, interactions, and potential therapeutic applications. By producing NXNL2 in a recombinant form, researchers aim to elucidate its structure-function relationship, investigate its role in photoreceptor survival, and explore its potential as a target for gene therapy approaches. Furthermore, the study of NXNL2 may also provide insights into the broader pathways involved in retinal degeneration, thereby enhancing our understanding of disease mechanisms and aiding in the development of innovative treatments for retinal diseases. As such, NXNL2 is not only a critical player in photoreceptor biology but also a promising candidate for future therapeutic strategies to combat retinal disorders.